Millennium Management’s Milestone Pharmaceuticals MIST Stock Holding History

Millennium Management’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-236,400	Closed	-$395K	–	6469
2023 Q4	$395K	Buy	+236,400	New	+$642K	﹤0.01%	4790
2023 Q1	–	Sell	-200,000	Closed	-$792K	–	6660
2022 Q4	$792K	Buy	200,000 +133,400	+200%	+$702K	﹤0.01%	4385
2022 Q3	$612K	Buy	+66,600	New	+$505K	﹤0.01%	4779
2021 Q1	–	Sell	-20,000	Closed	-$134K	–	6289
2020 Q4	$134K	Buy	+20,000	New	+$134K	﹤0.01%	4965

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Millennium Management's MIST Position: Q1 2026 in Review

Millennium Management increased its Milestone Pharmaceuticals (MIST) stake by 284% in Q1 2026, buying an estimated $2M and bringing the position to 1,544,325 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3948.

Millennium Management first reported a position in MIST in Q2 2019 and has held it in 26 quarters since. The position peaked at $8.57M in Q3 2022. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

Millennium Management held 1,544,325 shares of Milestone Pharmaceuticals worth $1.84M as of Q1 2026.
Millennium Management bought 1,141,690 Milestone Pharmaceuticals shares in Q1 2026, an estimated $2M.
Milestone Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3948 holding.
Millennium Management first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 26 quarters since.
Millennium Management's Milestone Pharmaceuticals position peaked at $8.57M in Q3 2022.
86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.